Genedrive makes progress with rapid Covid-19 test kit
23rd Feb 2022 15:34
(Sharecast News) - Molecular diagnostics company Genedrive updated the market on progress on the 'Genedrive COV19-ID' kit - its rapid point of care molecular test for Covid-19 - on Wednesday.
Read moreGenedrive submits new Covid-19 test for EU certification
29th Nov 2021 15:13
(Sharecast News) - Molecular diagnostics company Genedrive has submitted its new rapid point-of-care molecular Covid-19 test for CE-IVD certification in Europe, it announced on Monday.
Read moreRevenues fall, losses narrow for Genedrive
9th Nov 2021 15:02
(Sharecast News) - Near-patient molecular diagnostics company Genedrive reported revenue of £0.7m in its final results on Tuesday, down from £1.1m year-on-year.
Read moreGenedrive gets CE-IVD marking for new system platform
29th Sep 2021 13:08
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Wednesday that the new-generation 'Genedrive System' platform, which was developed to support the commercial launch of the 'Genedrive MT-RNR1' ID kit, had now received CE-IVD marking in anticipation of launch in the UK and the European Union.
Read moreGenedrive to seek CE mark clearance for MT-RNR1 assay
31st Aug 2021 12:05
(Sharecast News) - Molecular diagnostics company Genedrive said on Tuesday that it will soon launch its MT-RNR1 assay, used for the detection of antibiotic-induced hearing loss in newborns.
Read moreGenedrive makes progress with Covid-19 test development
1st Jul 2021 09:52
(Sharecast News) - Molecular diagnostics company Genedrive updated the market on the development of its 'COV19-ID Kit', a rapid point-of-care molecular test for SARS-CoV-2 detection designed for its 'Genedrive instrument', on Thursday.
Read moreGenedrive Covid-19 test formally approved in India
30th Apr 2021 13:16
(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that the 'Genedrive 96' SARS-CoV-2 kit had been formally approved by the Indian Council of Medical Research (ICMR).
Read moreGenedrive appointed to PHE microbiology supply framework
19th Apr 2021 12:07
(Sharecast News) - Molecular diagnostics company Genedrive has been successful with its tender to Public Health England (PHE) under Lot 1 of the National Microbiology Framework for diagnostic goods and services, it announced on Monday.
Read moreGenedrive notifies FDA of intent to distribute Covid test
16th Dec 2020 12:16
(Sharecast News) - Molecular diagnostics company Genedrive has notified the United States Food and Drug Association (FDA) of its intention to import and distribute its 'Genedrive 96 SARS-CoV-2 Kit' prior to an emergency use authorisation (EUA) determination, it announced on Wednesday.
Read moreGenedrive gets approval for Covid-19 kit in South Africa
30th Sep 2020 17:21
(Sharecast News) - Molecular diagnostics company Genedrive announced on Wednesday that its 'Genedrive 96' SARS-CoV-2 kit has received approval from the South African Health Products Regulatory Authority, having been submitted for evaluation in June.
Read moreGenedrive revenues tumble as Covid-19 hits pre-existing business activities
10th Jul 2020 10:15
(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tumble in the year ended 30 June due to the impact of the Covid-19 pandemic on pre-existing business activities.
Read moreGenedrive gets CE-mark for Covid-19 test kit
22nd May 2020 13:16
(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that its 'Genedrive 96 SARS-CoV-2 Kit' was now CE-IVD marked, and available for commercial sale across the European Union, including the UK.
Read moreGenedrives completes manufacturing milestone for Covid-19 test
1st May 2020 16:17
(Sharecast News) - Near-patient molecular diagnostics company Genedrive has completed the last significant manufacturing milestone in the co-development of the 'Genedrive 96 SARS-CoV-2' kit with Cytiva, it announced on Friday.
Read moreGenedrive upbeat on latest results from RNR1 kit testing
3rd Dec 2019 09:39
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.
Read moreGenedrive infant hearing loss test gets CE mark
18th Nov 2019 16:00
(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.
Read more